Aldeyra Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $20.0M | $12.0M | $14.6M | $8.5M | $3.3M |
| Accounts Receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $44.0M | $25.1M | $28.1M | $8.8M | $3.3M |
| Property, Plant & Equipment | $43.3K | $56.4K | $80.3K | $13.0K | — |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $44.2M | $25.2M | $28.2M | $8.8M | $3.7M |
| Liabilities | |||||
| Accounts Payable | $1.0M | $275.4K | $851.2K | $341.3K | $341.9K |
| Total Current Liabilities | $3.4M | $2.3M | $2.1M | $1.3M | $605.0K |
| Long-Term Debt | $1.2M | $1.2M | $1.2M | $1.2M | $1.1M |
| Total Liabilities | $4.6M | $3.5M | $3.3M | $2.5M | $5.6M |
| Stockholders' Equity | |||||
| Retained Earnings | $-99.6M | $-77.3M | $-58.6M | $-46.5M | $-41.3M |
| Total Stockholders' Equity | $39.6M | $21.6M | $24.9M | $6.3M | $-40.2M |